Pharmacokinetic and pharmacodynamic considerations of general anesthesia in pediatric subjects

References

• Hill AV. The possible effects of the aggregation of the molecules of haemoglobin on its dissociation curves. J Physiol. 1910;14:iv–vii.
   Google Scholar
• Dixon WJ. Staircase bioassay: the up-and-down method. Neurosci Biobehav Rev. 1991;15(1):47–50. Spring.
   Google Scholar
• Gorges M, Zhou G, Brant R, et al., Sequential allocation trial design in anesthesia: an introduction to methods, modeling, and clinical applications. Paediatr Anaesth. 2017;27(3): 240–247.
   Google Scholar
• Anderson BJ, Allegaert K, Holford NH. Population clinical pharmacology of children: general principles. Eur J Pediatr. 2006;165(11):741–746.
   Google Scholar
• Sheiner LB. The population approach to pharmacokinetic data analysis: rationale and standard data analysis methods. Drug Metab Rev. 1984;15(1–2):153–171.
   Google Scholar
• Holford NHG. The target concentration approach to clinical drug development. Clin Pharmacokinet. 1995;29(5):287–291.
   Google Scholar
• Anderson BJ, Allegaert K, Holford NH. Population clinical pharmacology of children: modelling covariate effects. Eur J Pediatr. 2006;165(12):819–829.
   Google Scholar
• Benet LZ. A Holy Grail of clinical pharmacology: prediction of drug pharmacokinetics and pharmacodynamics in the individual patient. Clin Pharmacol Ther. 2009;86(2):133–134.
   Google Scholar
• Nguyen TH, Mouksassi MS, Holford N, et al., Model evaluation of continuous data pharmacometric models: metrics and graphics. CPT Pharmacometrics Syst Pharmacol. 2017;6(2): 87–109. .
   Google Scholar
• Karlsson MO, Savic RM. Diagnosing model diagnostics [Review]. Clin Pharmacol Ther. 2007 Jul;82(1):17–20.
   Google Scholar
• Hines RN. Developmental expression of drug metabolizing enzymes: impact on disposition in neonates and young children. Int J Pharmaceutics. 2012;452(1–2):3–7.
   Google Scholar
• Anderson BJ, Holford NH. Mechanistic basis of using body size and maturation to predict clearance in humans. Drug Metab Pharmacokinet. 2009;24(1):25–36.
   Google Scholar
• Holford N, Heo YA, Anderson B. A pharmacokinetic standard for babies and adults. J Pharm Sci. 2013 May 6;102(9):2941–2952.
   Google Scholar
• Anderson BJ, Meakin GH. Scaling for size: some implications for paediatric anaesthesia dosing. Paediatr Anaesth. 2002;12(3):205–219.
   Google Scholar
• Anderson BJ, Holford NH. Mechanism-based concepts of size and maturity in pharmacokinetics. Annu Rev Pharmacol Toxicol. 2008;48(1):303–332.
   Google Scholar
• Eleveld DJ, Proost JH, Cortinez LI, et al. A general purpose pharmacokinetic model for propofol. Anesth Analg. 2014;118(6):1221–1237.
   Google Scholar
• Morse J, Hannam JA, Cortinez LI, et al., A manual propofol infusion regimen for neonates and infants. Paediatr Anaesth. 2019;29(9): 907–914.
   Google Scholar
• Eleveld DJ, Proost JH, Vereecke H, et al., An allometric model of remifentanil pharmacokinetics and pharmacodynamics. Anesthesiology. 2017;126(6):1005–1018.
   Google Scholar
• Rigby-Jones AE, Priston MJ, Sneyd JR, et al. Remifentanil-midazolam sedation for paediatric patients receiving mechanical ventilation after cardiac surgery. Brit J Anaesth. 2007;99(2):252–261. .
   Google Scholar
• Cortinez LI, Anderson BJ. Modeling the pharmacokinetics and pharmacodynamics of sevoflurane using compartment models in children and adults. Pediatr Anesth. 2018;28(10):834–840.
   Google Scholar
• Welzing L, Ebenfeld S, Dlugay V, et al. Remifentanil degradation in umbilical cord blood of preterm infants. Anesthesiology. 2011;114(3):570–577.
   Google Scholar
• Minto CF, Schnider TW, Egan TD, et al. Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. Model development. Anesthesiology. 1997;86(1):10–23.
   Google Scholar
• Anderson BJ, Bagshaw O. Practicalities of total intravenous anesthesia and target-controlled infusion in children. Anesthesiology. 2019;131(1):164–185. .
   Google Scholar
• Hines RN. Developmental expression of drug metabolizing enzymes: impact on disposition in neonates and young children. Int J Pharm. 2012 Jul 3;452(1-2):3–7.
   Google Scholar
• Ward RM, Drover DR, Hammer GB, et al. The pharmacokinetics of methadone and its metabolites in neonates, infants, and children. Pediatr Anesth. 2014 Mar 26;24(6):591–601.
   Google Scholar
• Stevens JC, Hines RN, Gu C, et al. Developmental expression of the major human hepatic CYP3A enzymes. J Pharm Exp Ther. 2003 Nov;307(2):573–582.
   Google Scholar
• Holford NH, Anderson BJ. Why standards are useful for predicting doses. Br J Clin Pharmacol. 2017;83(4):685–687.
   Google Scholar
• Potts AL, Anderson BJ, Warman GR, et al. Dexmedetomidine pharmacokinetics in pediatric intensive care–a pooled analysis. Pediatr Anesth. 2009;19(11):1119–1129.
   Google Scholar
• Holford NH, Ma SC, Anderson BJ. Prediction of morphine dose in humans. Pediatr Anesth. 2012 Mar;22(3):209–222.
   Google Scholar
• Rhodin MM, Anderson BJ, Peters AM, et al., Human renal function maturation: a quantitative description using weight and postmenstrual age. Pediatr Nephrol. 2009;24(1): 67–76.
   Google Scholar
• Anderson BJ, Hannam JA. A target concentration strategy to determine ibuprofen dosing in children. Pediatr Anesth. 2019;29(11):1107–1113.
   Google Scholar
• Saarenmaa E, Neuvonen PJ, Fellman V. Gestational age and birth weight effects on plasma clearance of fentanyl in newborn infants. J Pediatr. 2000;136(6):767–770.
   Google Scholar
• Allegaert K, van den Anker JN, de Hoon JN, et al. Covariates of tramadol disposition in the first months of life. Brit J Anaesth. 2008;100(4):525–532.
   Google Scholar
• Anderson BJ, Holford NH. Mechanistic basis of using body size and maturation to predict clearance in humans. Drug Metab Pharmacokinet. 2009;24(1):25–36.
   Google Scholar
• Allegaert K, Palmer GM, Anderson BJ. The pharmacokinetics of intravenous paracetamol in neonates: size matters most. Arch Dis Child. 2011;96(6):575–580.
   Google Scholar
• Anderson BJ, Pons G, Autret-Leca E, et al. Pediatric intravenous paracetamol (propacetamol) pharmacokinetics: a population analysis. Paediatr Anaesth. 2005;15(4):282–292.
   Google Scholar
• Schnider TW, Minto CF, Gambus PL, et al. The influence of method of administration and covariates on the pharmacokinetics of propofol in adult volunteers. Anesthesiology. 1998;88(5):1170–1182.
   Google Scholar
• Schnider TW, Minto CF, Shafer SL, et al. The influence of age on propofol pharmacodynamics. Anesthesiology. 1999;90(6):1502–1516.
   Google Scholar
• Eleveld DJ, Proost JH, Absalom AR, et al. Obesity and allometric scaling of pharmacokinetics. Clin Pharmacokinet. 2011;50(11):751–753. discussion 755-6.
   Google Scholar
• Dawes JM, Cooke EM, Hannam JA, et al., Oral morphine dosing predictions based on single dose in healthy children undergoing surgery. Paediatr Anaesth. 2017;27(1):28–36.
   Google Scholar
• Anderson BJ. van den Anker J. Why is there no morphine concentration-response curve for acute pain? Pediatr Anesth. 2014;24(3):233–238.
   Google Scholar
• Davis L, Britten JJ, Cholinesterase MM. Its significance in anaesthetic practice. Anaesthesia. 1997 Mar;52(3):244–260.
   Google Scholar
• Costa ACC, Coelho EB, Lanchote VL, et al. The SLCO1A2-189_-188InsA polymorphism reduces clearance of rocuronium in patients submitted to elective surgeries. Eur J Clin Pharmacol. 2017 Aug;73(8):957–963.
   Google Scholar
• Kelly LE, Rieder M, van den Anker J, et al. More codeine fatalities after tonsillectomy in North American children. Pediatrics. 2012 May;129(5):e1343–7.
   Google Scholar
• Eckhardt K, Li S, Ammon S, et al. Same incidence of adverse drug events after codeine administration irrespective of the genetically determined differences in morphine formation. Pain. 1998;76(1–2):27–33.
   Google Scholar
• Allegaert K, Holford N, Anderson BJ, et al. Tramadol and o-desmethyl tramadol clearance maturation and disposition in humans: a pooled pharmacokinetic study. Clin Pharmacokinet. 2015 Feb;54(2):167–178.
   Google Scholar
• Holford NH, Buclin T. Safe and effective variability-a criterion for dose individualization. Ther Drug Monit. 2012;34(5):565–568.
   Google Scholar
• Palomaki GE, Bradley LA, Douglas MP, et al. Can UGT1A1 genotyping reduce morbidity and mortality in patients with metastatic colorectal cancer treated with irinotecan? An evidence-based review. Genet Med. 2009;11(1):21–34.
   Google Scholar
• Sadhasivam S, Chidambaran V. Pharmacogenomics of opioids and perioperative pain management. Pharmacogenomics. 2012;13(15):1719–1740.
   Google Scholar
• Upton RN, Ludbrook GL. A physiological model of induction of anaesthesia with propofol in sheep. 1. Structure and estimation of variables. Br J Anaesth. 1997;79(4):497–504.
   Google Scholar
• Cortinez LI, Troconiz IF, Fuentes R. The influence of age on the dynamic relationship between end-tidal sevoflurane concentration and bispectral index. Anesth Anal. 2008;107(5):1573–1578.
   Google Scholar
• Vuyk J, Lichtenbelt BJ, Olofsen E, et al. Mixed-effects modeling of the influence of midazolam on propofol pharmacokinetics. Anesth Analg. 2009;108(5):1522–1530.
   Google Scholar
• Tod M, Jullien V, Pons G. Facilitation of drug evaluation in children by population methods and modelling. Clin Pharmacokinet. 2008;47(4):231–243.
   Google Scholar
• Pokela ML, Olkkola KT, Seppala T, et al. Age-related morphine kinetics in infants. Dev Pharmacol Ther. 1993;20(1–2):26–34.
   Google Scholar
• Peters JW, Anderson BJ, Simons SH, et al. Morphine metabolite pharmacokinetics during venoarterial extra corporeal membrane oxygenation in neonates. Clin Pharmacokinet. 2006;45(7):705–714.
   Google Scholar
• Anand KJ, Anderson BJ, Holford NH, et al. Morphine pharmacokinetics and pharmacodynamics in preterm and term neonates: secondary results from the NEOPAIN trial. Brit J Anaesth. 2008 Nov;101(5):680–689.
   Google Scholar
• Schwartz GJ, Work DF. Measurement and estimation of GFR in children and adolescents. Clin J Am Soc Nephrol. 2009;4(11):1832–1843.
   Google Scholar
• Ceriotti F, Boyd JC, Klein G, et al. Reference intervals for serum creatinine concentrations: assessment of available data for global application. Clin Chem. 2008 Mar;54(3):559–566.
   Google Scholar
• Paap CM, Nahata MC. Prospective evaluation of ten methods for estimating creatinine clearance in children with varying degrees of renal dysfunction. J Clin Pharm Ther. 1995;20(2):67–73.
   Google Scholar
• Cole M, Price L, Parry A, et al. Estimation of glomerular filtration rate in paediatric cancer patients using 51CR-EDTA population pharmacokinetics. Br J Cancer. 2004;90(1):60–64.
   Google Scholar
• Schwartz GJ, Haycock GB, Edelmann CM Jr., et al. A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics. 1976;58(2):259–263.
   Google Scholar
• Schwartz GJ, Feld LG, Langford DJ. A simple estimate of glomerular filtration rate in full-term infants during the first year of life. J Pediatr. 1984;104(6):849–854.
   Google Scholar
• Brion LP, Fleischman AR, McCarton C, et al. A simple estimate of glomerular filtration rate in low birth weight infants during the first year of life: noninvasive assessment of body composition and growth. J Pediatr. 1986;109(4):698–707.
   Google Scholar
• Blaschke TF. Protein binding and kinetics of drugs in liver diseases. Clin Pharmacokinet. 1977;2(1):32–44.
   Google Scholar
• Kaivosaari S, Toivonen P, Aitio O, et al. Regio- and stereospecific N-glucuronidation of medetomidine: the differences between UDP glucuronosyltransferase (UGT) 1A4 and UGT2B10 account for the complex kinetics of human liver microsomes. Drug Metab Dispos. 2008;36(8):1529–1537.
   Google Scholar
• Kohli U, Pandharipande P, Muszkat M, et al. CYP2A6 genetic variation and dexmedetomidine disposition. Eur J Clin Pharmacol. 2012;68(6):937–942.
   Google Scholar
• Servin F, Cockshott ID, Farinotti R, et al. Pharmacokinetics of propofol infusions in patients with cirrhosis. Br J Anaesth. 1990;65(2):177–183.
   Google Scholar
• Damian MA, Hammer GB, Elkomy MH, et al. Pharmacokinetics of dexmedetomidine in infants and children after orthotopic liver transplantation. Anesth Analg. 2018 Sep 5. EPub ahead of print. DOI:10.1213/ANE.0000000000003761.
   Google Scholar
• Anderson BJ, Holford NH. What is the best size predictor for dose in the obese child? Pediatr Anesth. 2017;27(12):1176–1184.
   Google Scholar
• Sumpter AL, Holford NH. Predicting weight using postmenstrual age–neonates to adults. Paediatr Anaesth. 2011;21(3):309–315.
   Google Scholar
• Cole TJ, Bellizzi MC, Flegal KM, et al. Establishing a standard definition for child overweight and obesity worldwide: international survey [Research Support, Non-U.S. Gov’t]. BMJ. 2000;320(7244):1240–1243.
   Google Scholar
• Collier H, Nasim M, Gandhi A. Prescribing in obese children: how good are paediatricians? Arch Dis Child. 2017;102(1):61–62.
   Google Scholar
• Anderson BJ, Holford NH. Getting the dose right for obese children. Arch Dis Child. 2017;102(1):54–55.
   Google Scholar
• Al-Sallami HS, Goulding A, Grant A, et al. Prediction of Fat-Free Mass in Children. Clin Pharmacokinet. 2015;54(11):1169–1178.
   Google Scholar
• Holford NHG, Anderson BJ. Allometric size: the scientific theory and extension to normal fat mass. Eur J Pharm Sci. 2017;109S:S59-S64.
   Google Scholar
• Cortinez LI, Anderson BJ, Penna A, et al., Influence of obesity on propofol pharmacokinetics: derivation of a pharmacokinetic model. Brit J Anaesth. 2010;105(4): 448–456.
   Google Scholar
• Eleveld DJ, Colin P, Absalom AR, et al., Pharmacokinetic-pharmacodynamic model for propofol for broad application in anaesthesia and sedation. Brit J Anaesth. 2018;120(5): 942–959.
   Google Scholar
• Hakim M, Anderson BJ, Walia H, et al., Acetaminophen pharmacokinetics in severely obese adolescents and young adults. Paediatr Anaesth. 2019;29(1): 20–26.
   Google Scholar
• Allegaert K, Olkkola KT, Owens KH, et al. Covariates of intravenous paracetamol pharmacokinetics in adults. BMC Anesthesiol. 2014;14(1):77.
   Google Scholar
• Cortinez LI, Anderson BJ. Advances in pharmacokinetic modeling: target controlled infusions in the obese. Curr Opin Anaesthesiol. 2018;31(4):415–422.
   Google Scholar
• Cortinez LI, Sepulveda P, Rolle A, et al., Effect-site target-controlled infusion in the obese: model derivation and performance assessment. Anesth Analg. 2018;127(4): 865–872.
   Google Scholar
• Diepstraten J, Chidambaran V, Sadhasivam S, et al. Propofol clearance in morbidly obese children and adolescents: influence of age and body size. Clin Pharmacokinet. 2012;51(8):543–551.
   Google Scholar
• Cortinez LI, Anderson BJ, Holford NH, et al. Dexmedetomidine pharmacokinetics in the obese. Eur J Clin Pharmacol. 2015;71(12):1501–1508.
   Google Scholar
• Allegaert K, Peeters MY, Verbesselt R, et al. Inter-individual variability in propofol pharmacokinetics in preterm and term neonates. Brit J Anaesth. 2007;99(6):864–870.
   Google Scholar
• Anderson BJ, Holford NHG. Negligible impact of birth on renal function and drug metabolism. Pediatr Anesth. 2018;28(11):1015–1021.
   Google Scholar
• Stephenson T. How children’s responses to drugs differ from adults. Br J Clin Pharmacol. 2005;59(6):670–673.
   Google Scholar
• Kelly LE, Sinha Y, Barker CIS, et al., Useful pharmacodynamic endpoints in children: selection, measurement, and next steps. Pediatr Res. 2018;83(6): 1095–1103.
   Google Scholar
• Sheiner LB, Stanski DR, Vozeh S, et al., Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to D-tubocurarine. Clin Pharmacol Ther. 1979;25(3): 358–371.
   Google Scholar
• Vega EA, Ibacache ME, Anderson BJ, et al. Rocuronium pharmacokinetics and pharmacodynamics in the adductor pollicis and masseter muscles. Acta Anaesthesiol Scand. 2016;60(6):734–746.
   Google Scholar
• Wierda JM, Meretoja OA, Taivainen T, et al. Pharmacokinetics and pharmacokinetic-dynamic modelling of rocuronium in infants and children. Brit J Anaesth. 1997;78(6):690–695.
   Google Scholar
• Nigrovic V, Amann A. Physiologic-pharmacologic interpretation of the constants in the Hill equation for neuromuscular block: a hypothesis. J Pharmacokinet Pharmacodyn. 2002;29(2):189–206.
   Google Scholar
• Goudsouzian NG, Standaert FG. The infant and the myoneural junction [Review]. Anesth Analg. 1986;65(11):1208–1217.
   Google Scholar
• Goudsouzian NG, Crone RK, Todres ID. Recovery from pancuronium blockade in the neonatal intensive care unit. Br J Anaesth. 1981;53(12):1303–1309.
   Google Scholar
• Cornelissen L, Kim SE, Lee JM, et al., Electroencephalographic markers of brain development during sevoflurane anaesthesia in children up to 3 years old. Br J Anaesth. 2018;120(6): 1274–1286.
   Google Scholar
• Cornelissen L, Kim SE, Purdon PL, et al. Age-dependent electroencephalogram (EEG) patterns during sevoflurane general anesthesia in infants. Elife. 2015;4:e06513.
   Google Scholar
• Fuentes R, Cortinez LI, Contreras V, et al., Propofol pharmacokinetic and pharmacodynamic profile and its electroencephalographic interaction with remifentanil in children. Pediatr Anesth. 2018;28(12): 1079–1085.
   Google Scholar
• Holford NHG, Sheiner LB. Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models. Clin Pharmacokinet. 1981;6(6):429–453.
   Google Scholar
• Hayden JC, Bardol M, Doherty DR, et al., Optimising clonidine dosage for sedation in mechanically ventilated children: a pharmacokinetic simulation study. Pediatr Anaesth. 2019;29(10): 1002–1010.
   Google Scholar
• Olofsen E, Dahan A. The dynamic relationship between end-tidal sevoflurane and isoflurane concentrations and bispectral index and spectral edge frequency of the electroencephalogram. Anesthesiology. 1999;90(5):1345–1353.
   Google Scholar
• Goodchild CS, Serrao JM, Sear JW, et al., Pharmacokinetic and pharmacodynamic analysis of afaxalone administered as a bolus intravenous injection of phaxan in a phase 1 randomized trial. Anesth Analg. 2020;130(3): 704–714.
   Google Scholar
• Potts AL, Anderson BJ, Holford NH, et al. Dexmedetomidine hemodynamics in children after cardiac surgery. Paediatr Anaesth. 2010;20(5):425–433.
   Google Scholar
• Anderson BJ, Woollard GA, Holford NH. Acetaminophen analgesia in children: placebo effect and pain resolution after tonsillectomy. Eur J Clin Pharmacol. 2001;57(8):559–569.
   Google Scholar
• Allegaert K, Naulaers G, Vanhaesebrouck S, et al. The paracetamol concentration-effect relation in neonates. Paediatr Anaesth. 2013;23(1):45–50.
   Google Scholar
• Dershwitz M, Walsh JL, Morishige RJ, et al. Pharmacokinetics and pharmacodynamics of inhaled versus intravenous morphine in healthy volunteers. Anesthesiology. 2000;93(3):619–628.
   Google Scholar
• Dahan A, Romberg R, Teppema L, et al. Simultaneous measurement and integrated analysis of analgesia and respiration after an intravenous morphine infusion. Anesthesiology. 2004;101(5):1201–1209.
   Google Scholar
• Yassen A, Olofsen E, Romberg R, et al. Mechanism-based PK/PD modeling of the respiratory depressant effect of buprenorphine and fentanyl in healthy volunteers. Clin Pharmacol Ther. 2007;81(1):50–58.
   Google Scholar
• Hannam JA, Anderson BJ. Contribution of morphine and morphine-6-glucuronide to respiratory depression in a child. Anaesth Intensive Care. 2012;40(5):867–870.
   Google Scholar
• Standing JF, Hammer GB, Sam WJ, et al. Pharmacokinetic-pharmacodynamic modeling of the hypotensive effect of remifentanil in infants undergoing cranioplasty. Pediatr Anesth. 2010;20(1):7–18.
   Google Scholar
• Anderson BJ, Holford NH. Leaving no stone unturned, or extracting blood from stone? Paediatr Anaesth. 2010;20(1):1–6.
   Google Scholar
• Chan PL, Holford NH. Drug treatment effects on disease progression. Annu Rev Pharmacol Toxicol. 2001;41(1):625–659.
   Google Scholar
• Hannam JA, Anderson BJ, Potts A. Acetaminophen, ibuprofen, and tramadol analgesic interactions after adenotonsillectomy. Pediatr Anesth. 2018;28(10):841–851.
   Google Scholar
• Anderson BJ, Holford NH, Woollard GA, et al. Perioperative pharmacodynamics of acetaminophen analgesia in children. Anesthesiology. 1999;90(2):411–421.
   Google Scholar
• Bateman H. The k-function, a particular case of the confluent hypergeometric function. Trans Am Math Soc. 1931;33(4):817–831.
   Google Scholar
• Anderson B, Cranswick N. The placebo (I shall please)–is it so pleasing in children? Paediatr Anaesth. 2005;15(10):809–813.
   Google Scholar
• Simmons K, Ortiz R, Kossowsky J, et al. Pain and placebo in pediatrics: a comprehensive review of laboratory and clinical findings. Pain. 2014;155(11):2229–2235.
   Google Scholar
• Weimer K, Gulewitsch MD, Schlarb AA, et al. Placebo effects in children: a review. Pediatr Res. 2013;74(1):96–102.
   Google Scholar
• Krummenacher P, Kossowsky J, Schwarz C, et al. Expectancy-induced placebo analgesia in children and the role of magical thinking. J Pain. 2014;15(12):1282–1293.
   Google Scholar
• Bjornsson MA, Simonsson US. Modelling of pain intensity and informative dropout in a dental pain model after naproxcinod, naproxen and placebo administration. Br J Clin Pharmacol. 2011;71(6):899–906.
   Google Scholar
• Benedetti F. Placebo and endogenous mechanisms of analgesia [Review]. Handb Exp Pharmacol. 2007;177:393–413.
   Google Scholar
• Marchand S, Gaumond I. Placebo and nocebo: how to enhance therapies and avoid unintended sabotage to pain treatment. Pain Manag. 2013;3(4):285–294.
   Google Scholar
• Zaccara G, Giovannelli F, Schmidt D. Placebo and nocebo responses in drug trials of epilepsy. Epilepsy Behav. 2015;43:128–134.
   Google Scholar
• Manchikanti L, Pampati V, Damron K. The role of placebo and nocebo effects of perioperative administration of sedatives and opioids in interventional pain management. Pain Physician. 2005;8(4):349–355.
   Google Scholar
• Potts AL, Cheeseman JF, Warman GR. Circadian rhythms and their development in children: implications for pharmacokinetics and pharmacodynamics in anesthesia [Review]. Pediatr Anesth. 2011;21(3):238–246.
   Google Scholar
• Brainard J, Gobel M, Bartels K, et al. Circadian rhythms in anesthesia and critical care medicine: potential importance of circadian disruptions. Semin Cardiothorac Vasc Anesth. 2015;19(1):49–60.
   Google Scholar
• Reinberg A, Reinberg MA. Circadian changes of the duration of action of local anaesthetic agents. Naunyn-Schmiedebergs Arch Pharmacol. 1977;297(2):149–152.
   Google Scholar
• Lemmer B, Wiemers R. Circadian changes in stimulus threshold and in the effect of a local anaesthetic drug in human teeth: studies with an electronic pulptester. Chronobiol Int. 1989;6(2):157–162.
   Google Scholar
• Debon R, Chassard D, Duflo F, et al. Chronobiology of epidural ropivacaine: variations in the duration of action related to the hour of administration. Anesthesiology. 2002;96(3):542–545.
   Google Scholar
• Cheeseman JF, Merry AF, Pawley MD, et al. The effect of time of day on the duration of neuromuscular blockade elicited by rocuronium. Anaesthesia. 2007;62(11):1114–1120.
   Google Scholar
• Levi FA, Zidani R, Vannetzel JM, et al. Chronomodulated versus fixed-infusion-rate delivery of ambulatory chemotherapy with oxaliplatin, fluorouracil, and folinic acid (leucovorin) in patients with colorectal cancer metastases: a randomized multi-institutional trial. J Natl Cancer Inst. 1994;86(21):1608–1617.
   Google Scholar
• Kamali F, Fry JR, Bell GD. Temporal variations in paracetamol absorption and metabolism in man. Xenobiotica. 1987;17(5):635–641.
   Google Scholar
• Halsas M, Hietala J, Veski P, et al. Morning versus evening dosing of ibuprofen using conventional and time-controlled release formulations. Int J Pharmaceut. 1999;189(2):179–185.
   Google Scholar
• Clench J, Reinberg A, Dziewanowska Z, et al. Circadian changes in the bioavailability and effects of indomethacin in healthy subjects. Eur J Clin Pharmacol. 1981;20(5):359–369.
   Google Scholar
• Mustofa M, Suryawati S, Dwiprahasto I, et al. The relative bioavailability of diclofenac with respect to time of administration. Br J Clin Pharmacol. 1991;32(2):246–247.
   Google Scholar
• Ollagnier M, Decousus H, Cherrah Y, et al. Circadian changes in the pharmacokinetics of oral ketoprofen. Clin Pharmacokinet. 1987;12(5):367–378.
   Google Scholar
• Bienert A, Bartkowska-Sniatkowska A, Wiczling P, et al. Assessing circadian rhythms during prolonged midazolam infusion in the pediatric intensive care unit (PICU) children. Pharmacol Rep. 2013;65(1):107–121.
   Google Scholar
• Bienert A, Kusza K, Wawrzyniak K, et al. Assessing circadian rhythms in propofol PK and PD during prolonged infusion in ICU patients. J Pharmacokinet Pharmacodyn. 2010 Jun;37(3):289–304.
   Google Scholar
• Lichtenbelt BJ, Olofsen E, Dahan A, et al. Propofol reduces the distribution and clearance of midazolam. Anesth Analg. 2010 June 1;110(6):1597–1606.
   Google Scholar
• Vuyk J, Lichtenbelt BJ, Olofsen E, et al. Mixed-effects modeling of the influence of midazolam on propofol pharmacokinetics. Anesth Analg. 2009;108(5):1522–1530.
   Google Scholar
• van den Berg JP, Vereecke HE, Proost JH, et al., Pharmacokinetic and pharmacodynamic interactions in anaesthesia. A review of current knowledge and how it can be used to optimize anaesthetic drug administration. Br J Anaesth. 2017;118(1): 44–57.
   Google Scholar
• Greco WR, Park HS, Rustum YM. Application of a new approach for the quantitation of drug synergism to the combination of cis-diamminedichloroplatinum and 1-beta-D-arabinofuranosylcytosine [Research Support, U.S. Gov’t, P.H.S.]. Cancer Res. 1990;50(17):5318–5327.
   Google Scholar
• Minto C, Vuyk J. Response surface modelling of drug interactions. Adv Exp Med Biol. 2003;523:35–43.
   Google Scholar
• Jeleazcov C, Ihmsen H, Schmidt J, et al. Pharmacodynamic modelling of the bispectral index response to propofol-based anaesthesia during general surgery in children. Brit J Anaesth. 2008;100(4):509–516. .
   Google Scholar
• Hannam JA, Anderson BJ, Mahadevan M, et al. Postoperative analgesia using diclofenac and acetaminophen in children. Pediatr Anesth. 2014;24(9):953–961.
   Google Scholar
• Sherwin CM, Stockmann C, Grimsrud K, et al., Development of an optimal sampling schedule for children receiving ketamine for short-term procedural sedation and analgesia [Research Support, Non-U.S. Gov’t]. Paediatr Anaesth. 2015;25(2): 211–216.
   Google Scholar
• Szmuk P, Andropoulos D, McGowan F, et al. an open label pilot study of a dexmedetomidine-remifentanil-caudal anesthetic for infant lower abdominal/lower extremity surgery: the T REX pilot study. Pediatr Anesth. 2019 Jan;29(1):59–67.
   Google Scholar
• Anderson BJ, Holford NH. Tips and traps analyzing pediatric PK data. Pediatr Anesth. 2011;21(3):222–237.
   Google Scholar
• Thomas J, Corson NI, Meinhold A, et al., Neurological excitation in a 6-week-old male infant after morphine overdose. Pediatr Anesth. 2019;29(10): 1060–1061.
   Google Scholar